A Payor’s Perspective on Spatial Biology: Evidence Requirements for Novel Technologies
Time: 2:45 pm
day: Conference Day 2
Details:
- Understanding the evidence requirements and approval criteria for novel technologies in drug development, with a focus on the U.S. regulatory environment
- Identifying the current state of research, future directions, and key emphasis areas for demonstrating drug efficacy, including addressing unmet clinical needs and assessing alternatives
- Guiding R&D and commercialization efforts by highlighting critical clinical questions, necessary outcomes, and criteria for demonstrating clinical equivalence or superiority to ensure successful acceptance for reimbursement